ArticleFrontiers in immunology2022

Early immunological responses to the mRNA SARS-CoV-2 vaccine in patients with neuromuscular disorders.

Hideyuki Iwayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.